Kress S, Schilling D, Riemann J F
Medizinische Klinik C, Klinikum Ludwigshafen.
Med Klin (Munich). 1998 Aug 15;93(8):486-91. doi: 10.1007/BF03042598.
The efficiency of stress ulcer prophylaxis in the prevention of gastrointestinal bleeding in critically ill patients has led to its widespread use. The lower incidence of stress ulcer bleeding, the side-effects and the cost of the prophylaxis have made it necessary targeting this preventive therapy to those patients most likely to benefit. Metaanalysis of studies on patients who received no stress ulcer prophylaxis showed few critically ill patients with important gastrointestinal bleeding.
Patients who benefit most from receiving stress ulcer prophylaxis are critically ill patients with coagulopathy, or those requiring mechanical ventilation for more than two days. In patients with headinjuries, widespread burns or severe hypotension, the effects of stress ulcer prophylaxis have not been fully researched, but we would recommend administering stress ulcer prophylaxis in these cases.
Following a recent metaanalysis, stress ulcer prophylaxis is performed either with H2-blockers (ranitidine, famotidine) or sucralfate.
应激性溃疡预防在预防重症患者胃肠道出血方面的有效性已导致其广泛应用。应激性溃疡出血发生率较低、预防措施的副作用及成本使得有必要将这种预防性治疗针对最可能受益的患者。对未接受应激性溃疡预防的患者进行的研究的荟萃分析显示,很少有重症患者发生严重胃肠道出血。
最受益于接受应激性溃疡预防的患者是患有凝血病的重症患者,或需要机械通气超过两天的患者。对于头部受伤、大面积烧伤或严重低血压患者,应激性溃疡预防的效果尚未得到充分研究,但我们建议在这些情况下给予应激性溃疡预防治疗。
根据最近的一项荟萃分析,应激性溃疡预防可使用H2受体阻滞剂(雷尼替丁、法莫替丁)或硫糖铝进行。